MAPK8 and colorectal carcinoma: Finally, HCT-116 CRC cells were pretreated with DMSO (vehicle), SP600125 (a JNK1/2 inhibitor at 20 μM), or SB203580 (a p38 inhibitor at 10 μM) for 30 min.